Daiken Biomedical Co., Ltd. (TPE:7780)
26.70
-0.20 (-0.74%)
At close: Jan 30, 2026
48.75% (1Y)
| Market Cap | 21.63B +100.8% |
| Revenue (ttm) | 1.78B +42.7% |
| Net Income | 268.63M +116.5% |
| EPS | 0.44 +21.6% |
| Shares Out | 810.02M |
| PE Ratio | 61.11 |
| Forward PE | 50.76 |
| Dividend | 0.40 (1.51%) |
| Ex-Dividend Date | Nov 24, 2025 |
| Volume | 3,888,328 |
| Average Volume | 15,568,966 |
| Open | 27.30 |
| Previous Close | 26.90 |
| Day's Range | 26.65 - 27.30 |
| 52-Week Range | 14.65 - 40.10 |
| Beta | n/a |
| RSI | 68.87 |
| Earnings Date | Apr 22, 2026 |